Ceramide Inhibits Antigen Uptake and Presentation by Dendritic Cells
Open Access
- 1 December 1996
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 184 (6) , 2411-2416
- https://doi.org/10.1084/jem.184.6.2411
Abstract
Ceramides are intramembrane diffusible mediators involved in transducing signals originated from a variety of cell surface receptors. Different adaptive and differentiative cellular responses, including apoptotic cell death, use ceramide-mediated pathways as an essential part of the program. Here, we show that human dendritic cells respond to CD40 ligand, as well as to tumor necrosis factor-α and IL-1β, with intracellular ceramide accumulation, as they are induced to differentiate. Dendritic cells down-modulate their capacity to take up soluble antigens in response to exogenously added or endogenously produced ceramides. This is followed by an impairment in presenting soluble antigens to specific T cell clones, while cell viability and the capacity to stimulate allogeneic responses or to present immunogenic peptides is fully preserved. Thus, ceramide-mediated pathways initiated by different cytokines can actively modulate professional antigen-presenting cell function and antigen-specific immune responses.Keywords
This publication has 34 references indexed in Scilit:
- Parietaria judaica–specific T-cell clones from atopic patients: Heterogeneity in restriction, Vβ usage, and cytokine profileJournal of Allergy and Clinical Immunology, 1996
- Does endotoxin stimulate cells by mimicking ceramide?Immunology Today, 1995
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Programmed Cell Death Induced by CeramideScience, 1993
- Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1βScience, 1993
- Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomesCell, 1991
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cellsNature, 1990
- Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ERCell, 1989